Standigm is a biotechnology company that specializes in artificial intelligence-driven drug discovery. The company focuses on leveraging advanced computational methods to identify new therapeutic candidates and optimize drug development processes. Standigm aims to enhance the efficiency and effectiveness of pharmaceutical research by integrating machine learning and data analytics into various stages of drug discovery, ultimately accelerating the timeline for bringing new drugs to market.